MicroRNA-613 suppresses proliferation, migration and invasion of osteosarcoma by targeting c-MET

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• MicroRNA-613 (miR-613) regulates gene expression posttranscriptionally and is implicated in various cancers.
• The specific role of miR-613 in osteosarcoma (OS) pathogenesis was previously unclear.

Purpose of the Study:

• To investigate the expression patterns and functional significance of miR-613 in osteosarcoma.
• To identify the molecular targets and signaling pathways regulated by miR-613 in OS.

Main Methods:

• Quantitative real-time PCR to assess miR-613 expression in OS tissues and cell lines.
• Cell proliferation, colony formation, migration, and invasion assays to evaluate miR-613 function.
• Bioinformatic analysis and luciferase reporter assays to identify miR-613 targets.
• Western blotting and rescue experiments to validate target interaction and pathway modulation.

Main Results:

• miR-613 was significantly downregulated in OS tissues and cell lines, inversely correlated with advanced TNM stage and lymph node metastasis.
• Overexpression of miR-613 suppressed OS cell proliferation, colony formation, migration, and invasion, inhibiting epithelial-mesenchymal transition (EMT).
• Cellular-mesenchymal to epithelial transition factor (c-MET) was identified as a direct target of miR-613; miR-613 inhibited c-MET expression and the PI3K/Akt/mTOR pathway. Overexpression of c-MET partially rescued miR-613's suppressive effects.

Conclusions:

• miR-613 functions as a tumor suppressor in osteosarcoma by targeting c-MET and inhibiting downstream signaling pathways.
• Restoring miR-613 expression may represent a novel therapeutic strategy for osteosarcoma.